Your browser doesn't support javascript.
loading
Biochemical Properties of TAK-828F, a Potent and Selective Retinoid-Related Orphan Receptor Gamma t Inverse Agonist.
Nakagawa, Hideyuki; Koyama, Ryoukichi; Kamada, Yusuke; Ochida, Atsuko; Kono, Mitsunori; Shirai, Junya; Yamamoto, Satoshi; Ambrus-Aikelin, Geza; Sang, Bi-Ching; Nakayama, Masaharu.
Afiliación
  • Nakagawa H; Biomolecular Research Laboratories, Pharmaceutical Research Division, Takeda Pharmaceutical Company Ltd., Fujisawa, Japanhideyuki.nakagawa@takeda.com.
  • Koyama R; Biomolecular Research Laboratories, Pharmaceutical Research Division, Takeda Pharmaceutical Company Ltd., Fujisawa, Japan.
  • Kamada Y; Biomolecular Research Laboratories, Pharmaceutical Research Division, Takeda Pharmaceutical Company Ltd., Fujisawa, Japan.
  • Ochida A; Immunology Unit, Pharmaceutical Research Division, Takeda Pharmaceutical Company Ltd., Fujisawa, Japan.
  • Kono M; Immunology Unit, Pharmaceutical Research Division, Takeda Pharmaceutical Company Ltd., Fujisawa, Japan.
  • Shirai J; Immunology Unit, Pharmaceutical Research Division, Takeda Pharmaceutical Company Ltd., Fujisawa, Japan.
  • Yamamoto S; Immunology Unit, Pharmaceutical Research Division, Takeda Pharmaceutical Company Ltd., Fujisawa, Japan.
  • Ambrus-Aikelin G; Takeda California, Pharmaceutical Research Division, Takeda Pharmaceutical Company Ltd., Fujisawa, Japan.
  • Sang BC; Takeda California, Pharmaceutical Research Division, Takeda Pharmaceutical Company Ltd., Fujisawa, Japan.
  • Nakayama M; Biomolecular Research Laboratories, Pharmaceutical Research Division, Takeda Pharmaceutical Company Ltd., Fujisawa, Japan.
Pharmacology ; 102(5-6): 244-252, 2018.
Article en En | MEDLINE | ID: mdl-30134246
BACKGROUND/AIMS: Retinoid-related orphan receptor gamma t (RORγt) is a master regulator of T helper 17 cells that plays a pivotal role in the production of inflammatory cytokines including interleukin (IL)-17. Therefore, RORγt has attracted much attention as a target receptor for the treatment of inflammatory diseases including rheumatoid arthritis, multiple sclerosis, inflammatory bowel diseases, and psoriasis. This study aims to characterize TAK-828F, a potent and selective RORγt inverse agonist. METHODS: The biochemical properties of TAK-828F were evaluated using Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay, surface plasmon resonance (SPR) biosensor assay, cofactor recruitment assay, reporter assay, and IL-17 expression assay. RESULTS: TR-FRET binding assay and SPR biosensor assay revealed rapid, reversible, and high affinity binding of TAK-828F to RORγt. The cofactor recruitment assay showed that TAK-828F inhibited the recruitment of steroid receptor coactivator-1 to RORγt. Furthermore, TAK-828F inhibited the transcriptional activity of human and mouse RORγt with selectivity against human RORα and RORß. TAK-828F also suppressed IL-17 production in Jurkat cells, overexpressing human RORγt. CONCLUSION: These favorable properties will be of advantage in the evaluation of TAK-828F in clinical studies for inflammatory diseases. Furthermore, these findings demonstrate that TAK-828F could serve as a pharmacological tool for further studies of RORγt and inflammatory diseases.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Sulfonas / Benzofuranos / Receptores Nucleares Huérfanos Límite: Animals / Humans Idioma: En Revista: Pharmacology Año: 2018 Tipo del documento: Article Pais de publicación: Suiza

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Sulfonas / Benzofuranos / Receptores Nucleares Huérfanos Límite: Animals / Humans Idioma: En Revista: Pharmacology Año: 2018 Tipo del documento: Article Pais de publicación: Suiza